Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219269 · ClinicalTrials.gov registry record
A Complex Contraception Registry
A clinical trial of Cancer and Diabetes, sponsored by University of California, San Diego.
- Completed
- Registry status
- 97
- Enrollment target
- 5
- Study locations
NCT02219269 is a study of Cancer and Diabetes that has completed, run by University of California, San Diego. The registered enrollment target is 97 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT02219269, a study of Cancer and Diabetes, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigators will conduct a prospective observational cohort study to investigate factors that influence contraceptive method utilization among women with medical conditions. The investigators will also investigate how women with medical conditions access to contraception and family planning fellowship trained specialist. After the baseline questionnaire, there be a 3 month and 6 month follow up questionnaire to investigate continuation and satisfaction with the contraceptive method. This study is unique because it will allow us to explore doing collaborative family planning research at the multiple UC medical campuses.
Conditions Studied
Study Locations (5)
California
- UCLA - Los Angeles
- UC Irvine - Orange
- UC Davis - Sacramento
- UCSD - San Diego
- UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02219269
The ClinicalTrials.gov registry entry for NCT02219269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02219269 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02219269 about?
NCT02219269 is a clinical study titled "A Complex Contraception Registry". The investigators will conduct a prospective observational cohort study to investigate factors that influence contraceptive method utilization among women with medical conditions. The investigators will also investigate how women with medical conditions access to contraception and family planning fe...
What is the current status of trial NCT02219269?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2014-06. Estimated completion is 2015-06.
What conditions does trial NCT02219269 study?
This clinical trial studies the following conditions: Cancer, Diabetes, Epilepsy, Cardiovascular Disease, Migraine.
Who is sponsoring clinical trial NCT02219269?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02219269 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.